Telomir Pharmaceuticals Inc (NASDAQ:TELO)’s traded shares stood at 0.33 million during the last session, with the company’s beta value hitting 0.16. At the close of trading, the stock’s price was $2.59, to imply an increase of 3.19% or $0.08 in intraday trading. The TELO share’s 52-week high remains $8.40, putting it -224.32% down since that peak but still an impressive 9.27% since price per share fell to its 52-week low of $2.35. The company has a valuation of $77.08M, with an average of 0.16 million shares in intraday trading volume over the past 10 days and average of 165.19K shares over the past 3 months.
Telomir Pharmaceuticals Inc (NASDAQ:TELO) trade information
After registering a 3.19% upside in the last session, Telomir Pharmaceuticals Inc (TELO) has traded red over the past five days. The 5-day price performance for the stock is 1.57%, and -17.25% over 30 days. With these gigs, the year-to-date price performance is -37.14%. Short interest in Telomir Pharmaceuticals Inc (NASDAQ:TELO) saw shorts transact 2.08 million shares and set a 9.93 days time to cover.
TELO Dividends
Telomir Pharmaceuticals Inc has its next earnings report out on 2025-Feb-03. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Telomir Pharmaceuticals Inc (NASDAQ:TELO)’s Major holders
Telomir Pharmaceuticals Inc insiders hold 34.17% of total outstanding shares, with institutional holders owning 12.14% of the shares at 18.45% float percentage. In total, 12.14% institutions holds shares in the company, led by BLACKROCK INC.. As of 2024-06-30, the company held over 87899.0 shares (or 0.2969% of shares), all amounting to roughly $0.42 million.
The next major institution holding the largest number of shares is GEODE CAPITAL MANAGEMENT, LLC with 66355.0 shares, or about 0.2241% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $0.32 million.
We also have VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF as the top two Mutual Funds with the largest holdings of the Telomir Pharmaceuticals Inc (TELO) shares. Going by data provided on Dec 31, 2024 , VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund holds roughly 833.23 shares. This is just over 2.80% of the total shares, with a market valuation of $2.16 million. Data from the same date shows that the other fund manager holds a little less at 456.89, or 1.54% of the shares, all valued at about 1.18 million.
